Market Place
Sourcing Support
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Enforcement Report - Week of October 11, 2023
11 Oct 2023 //
FDA
Leading Pharma`s Generic Oxybutynin Chloride Receives Approval In US
07 Apr 2020 //
FDA
Novast labs`s Generic Oxybutynin Chloride Receives Approval in US
30 Oct 2019 //
FDA
Emcure Pharms Oxybutynin Chloride Receives Approval in US
16 May 2019 //
FDA
Emcure Pharms Oxybutynin Chloride Receives Approval in US
14 May 2019 //
FDA
Ajanta Pharma`s Generic Oxybutynin Chloride Receives Approval in US
01 Mar 2019 //
FDA
Invatech Pharma`s Generic Oxybutynin Chlroride Receives Approval in US
08 Feb 2019 //
FDA
Enforcement Report - Week of December 26, 2018
26 Dec 2018 //
FDA
Tulex Pharms` Generic Oxybutynin Chloride Receives Approval in US
08 Sep 2018 //
FDA
Par Pharm’s Generic Oxybutynin Chloride Receives Approval In US
31 May 2018 //
FDA
Abhai’s Generic Oxybutynin Chloride Receives Approval In US
28 Dec 2017 //
FDA
Appco Pharma’s Generic Oxybutynin Chloride Receives Approval In US
26 Dec 2017 //
FDA
Novitium Pharma’s Generic Oxybutynin Chloride Receives Approval In US
26 Oct 2017 //
FDA
Zydus Pharm’s Generic Oxybutynin Chloride Receives Approval In US
28 Jun 2017 //
FDA
USFDA gives nod to Zydus Cadila`s overactive bladder tablets
27 Jun 2017 //
MONEYCONTROL
Amneal`s Generic Oxybutynin Cl approved in US for bladder difficulties
24 Nov 2015 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.